Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics.
Rani Therapeutics Holdings stock last closed at $2.41, down 3.98% from the previous day, and has increased 21.72% in one year. It has overperformed other stocks in the Biotechnology industry by 0.13 percentage points. Rani Therapeutics Holdings stock is currently +26.84% from its 52-week low of $1.90, and -72.46% from its 52-week high of $8.75.
As of Nov 8, 2024, there are 53.41M shares of RANI outstanding. The market cap of RANI is $128.71M. In the last 24 hours, 630,570 RANI shares were traded.
How to Buy Rani Therapeutics Holdings Stock
Not sure how to invest in Rani Therapeutics Holdings stock? Here's how.
Figure out where to buy Rani Therapeutics Holdings stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Rani Therapeutics Holdings stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Select your method of payment and add your information.
Evaluate Rani Therapeutics Holdings stock: The Rani Therapeutics Holdings ticker symbol is RANI. Is Rani Therapeutics Holdings stock a good investment? Should you buy shares of RANI? How do RANI's underlying business fundamentals look? Do top analysts think Rani Therapeutics Holdings is a good buy? Why has RANI's stock price moved recently? (Hint: Our stock analysis website can help you decide if RANI is a good stock to buy).
Execute your RANI trade: Decide if you will purchase RANI shares at the current market price or use a limit order to purchase RANI shares at a specific price.
Get notifications regarding your RANI investment: Create a watchlist to watch your new investment in Rani Therapeutics Holdings stock.
Step 1: Figure out where to buy Rani Therapeutics Holdings stock
You need an online brokerage account to access the NASDAQ market and buy RANI stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal info so you can buy RANI stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Rani Therapeutics Holdings stock
After you have chosen the best place to buy Rani Therapeutics Holdings stock, it's critical to analyze their stock prior to buying, so you can wrap your head around the risk and upside.
Rani Therapeutics Holdings quick stats
RANI Price
$2.41
1w %
4.33%
1y %
21.72%
5y %
N/A
P/E
-2.04x
P/B
45.4x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$30.58M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$128.71M
Next Earnings
N/A
Next Dividend
N/A
Rani Therapeutics Holdings Fundamentals
WallStreetZen was created to help average investors do more in-depth fundamental analysis quickly.
Last year, RANI revenue was $0.00. In the past three year, RANI's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 71.52%.
Over the past 12 months, insiders at RANI have sold more shares than they have bought.
South Cone Investments Limited Partnership, 10% Owner of RANI, was the latest RANI insider to sell. They sold $8,435,947.34 worth of RANI shares on Oct 15, 2024.
No, Rani Therapeutics Holdings doesn't provide an income stream by paying out dividends.
RANI Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your RANI trade
There are two primary options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open Trade button and your broker will place the order.
If you want more assistance investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Rani Therapeutics Holdings share?
As of Nov 8, 2024, it costs $2.41 to buy one share of Rani Therapeutics Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.415 shares of RANI.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.